Back to Agenda
SESSION 2 INTRODUCTION TO BENEFIT/RISK METHODOLOGIES
Speaker(s)
INTRODUCTION TO BENEFIT/RISK METHODOLOGY
Michael Forstner, PHD, MPH, MSC
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice
Have an account?